Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: BCL6 is required for the initiation and maintenance of chronic myeloid leukemia

OTHER RELATED OMICS DATASETS IN: E-GEOD-20987

PROVIDER: PRJNA135225 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR085463.fastq.gz	Fastqsanger.gz
	SRR085464.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

BCL6 is required for the initiation and maintenance of chronic myeloid leukemia

Project description:We identified the BCL6 protooncogene as a critical downstream effector of FoxO3A in self-renewal signaling of CML-initiating cells. BCL6 represses Arf and p53 in CML cells and is required for leukemia stem cell maintenance, colony formation and initiation of leukemia in transplant recipients. Importantly, peptide inhibition of BCL6 in human CML cells compromises colony formation and leukemia-initiation in xenotransplanted mouse recipients. These findings identify peptide-inhibition of BCL6 as a novel strategy to eradicate leukemia-initiating cells in CML. Identification of BCL6 binding sites in human CML cell line JURL-MK1

2011-09-15 | E-GEOD-26085 | biostudies-arrayexpress

BCL6 is required for the initiation and maintenance of chronic myeloid leukemia

2011-09-15 | GSE26085 | GEO

Homo sapiens

Project description:Whole-exome sequencing of chronic myeloid leukemia

| PRJNA213438 | ENA

Homo sapiens

Project description:RECURRENT SETBP1 MUTATIONS IN ATYPICAL CHRONIC MYELOID LEUKEMIA

| PRJNA179284 | ENA

Homo sapiens

Project description:shRNA Screening Identifies JMJD1C as being required for Leukemia Maintenance

| PRJNA215939 | ENA

STAP-1 is Required for Maintenance of Leukemic Stem Cells in Chronic Myeloid Leukemia.

Project description:STAP-1 is Required for Maintenance of Leukemic Stem Cells in Chronic Myeloid Leukemia.

| PRJNA525992 | ENA

Homo sapiens

Project description:SNP array data for 56 chronic myeloid leukemia samples.

| PRJNA105227 | ENA

Homo sapiens

Project description:Transcriptome characterization of chronic myeloid leukemia by RNA sequencing

| PRJNA390519 | ENA

Identification of targets regulated by SELP in HSC

Project description:To understand the underlying mechanism by which Alox15 gene is required by HSCs, we performed a comparative DNA microarray analysis using total RNA isolated from wild type Lin-Sca-1+c-Kit+, SELP-/- Lin-Sca-1+c-Kit+. The result was validated by quantitative real-time PCR analysis of wild type Lin-Sca-1+c-Kit+ and SELP-/- Lin-Sca-1+c-Kit+. Cancer stem cells are responsible for the initiation and maintenance of some types of cancer, and few effective target genes in these stem cells have been identified. Here we show that the selp is essential for the survival of leukemia stem cells (LSCs) in BCR-ABL-induced chronic myeloid leukemia (CML). To understand the underlying mechanism through which SELP regulates the function of HSCs, the gene expression profiles between WT and Selp-/- HSCs were compared. To understand the underlying mechanism through which SELP regulates the function of HSCs, the gene expression profiles between WT and Selp-/- HSCs were compared.

2014-05-09 | E-GEOD-57459 | biostudies-arrayexpress

GFI1 is pivotal for AML1-ETO positive acute myeloid leukemia

Project description:AML1-ETO (Acute Myeloid Leukemia 1-Eight Twenty One) caused by the translocation t(8;21)(q22;q22) is a mutated transcription factor contributing to AML development. Although associated with a favorable prognosis, half of the patients fail to achieve long-term survival. We examined the role of the transcription factor Growth factor independence 1 (GFI1) in the initiation and progression of leukemia and exploited the use of a drug targeting GFI1 expression in the context of AML1-ETO associated AML. We could show that GFI1 is required for maintenance of AML1-ETO associated leukemia and that loss of GFI1 or targeting GFI1 expression impedes leukemia initiation and progression and could be a potential new therapeutic strategy for patients failing to respond to chemotherapy.

2018-07-13 | GSE103255 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data